These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38273472)

  • 1. Adherence to allopurinol in patients with gout: further insights generate further questions.
    Robinson PC
    Lancet Rheumatol; 2020 May; 2(5):e249-e250. PubMed ID: 38273472
    [No Abstract]   [Full Text] [Related]  

  • 2. Allopurinol adherence among patients with gout: an Italian general practice database study.
    Mantarro S; Capogrosso-Sansone A; Tuccori M; Blandizzi C; Montagnani S; Convertino I; Antonioli L; Fornai M; Cricelli I; Pecchioli S; Cricelli C; Lapi F
    Int J Clin Pract; 2015 Jul; 69(7):757-65. PubMed ID: 25683693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimizing adherence to allopurinol for gout: patients' perspectives.
    Spragg JCJ; Michael TJF; Aslani P; Coleshill MJ; Chan JS; Day RO; Stocker SL
    Br J Clin Pharmacol; 2023 Jul; 89(7):1978-1991. PubMed ID: 36607199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modifiable factors associated with allopurinol adherence and outcomes among patients with gout in an integrated healthcare system.
    Rashid N; Coburn BW; Wu YL; Cheetham TC; Curtis JR; Saag KG; Mikuls TR
    J Rheumatol; 2015 Mar; 42(3):504-12. PubMed ID: 25512479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rates of adherence and persistence with allopurinol therapy among gout patients in Israel.
    Zandman-Goddard G; Amital H; Shamrayevsky N; Raz R; Shalev V; Chodick G
    Rheumatology (Oxford); 2013 Jun; 52(6):1126-31. PubMed ID: 23392592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medication adherence among gout patients initiated allopurinol: a retrospective cohort study in the Clinical Practice Research Datalink (CPRD).
    Scheepers LEJM; Burden AM; Arts ICW; Spaetgens B; Souverein P; de Vries F; Boonen A
    Rheumatology (Oxford); 2018 Sep; 57(9):1641-1650. PubMed ID: 29893941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allopurinol Medication Adherence as a Mediator of Optimal Outcomes in Gout Management.
    Coburn BW; Bendlin KA; Sayles H; Meza J; Russell CL; Mikuls TR
    J Clin Rheumatol; 2017 Sep; 23(6):317-323. PubMed ID: 28816767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adherence and persistence to urate-lowering therapies in the Irish setting.
    McGowan B; Bennett K; Silke C; Whelan B
    Clin Rheumatol; 2016 Mar; 35(3):715-21. PubMed ID: 25409858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Quality of treatment in gouty patients considering EULAR recommendations].
    Radak-Perović M; Zlatković-Svenda M
    Srp Arh Celok Lek; 2012; 140(11-12):717-21. PubMed ID: 23350244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allopurinol use in a New Zealand population: prevalence and adherence.
    Horsburgh S; Norris P; Becket G; Arroll B; Crampton P; Cumming J; Keown S; Herbison P
    Rheumatol Int; 2014 Jul; 34(7):963-70. PubMed ID: 24390636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allopurinol: insights from studies of dose-response relationships.
    Day RO; Kannangara DR; Stocker SL; Carland JE; Williams KM; Graham GG
    Expert Opin Drug Metab Toxicol; 2017 Apr; 13(4):449-462. PubMed ID: 27927043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allopurinol adherence and its predictors in gout: a national cohort study in US veterans.
    Singh JA; Richman J; Yang S; Bridges SL; Saag K
    Lancet Rheumatol; 2020 May; 2(5):e281-e291. PubMed ID: 33215163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of an adherence-enhancing intervention for gout based on real-world data.
    Lin LW; Teng GG; Lim AYN; Yoong JS; Zethraeus N; Wee HL
    Int J Rheum Dis; 2019 Apr; 22(4):545-554. PubMed ID: 30556300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Non-Adherence and Flare Resolution on the Cost-Effectiveness of Treatments for Gout: Application of a Linked Pharmacometric/Pharmacoeconomic Model.
    Hill-McManus D; Marshall S; Soto E; Lane S; Hughes D
    Value Health; 2018 Dec; 21(12):1373-1381. PubMed ID: 30502780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gout medication treatment patterns and adherence to standards of care from a managed care perspective.
    Sarawate CA; Brewer KK; Yang W; Patel PA; Schumacher HR; Saag KG; Bakst AW
    Mayo Clin Proc; 2006 Jul; 81(7):925-34. PubMed ID: 16835972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Why Do Patients With Gout Not Take Allopurinol?
    Emad Y; Dalbeth N; Weinman J; Chalder T; Petrie KJ
    J Rheumatol; 2022 Jun; 49(6):622-626. PubMed ID: 35169055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adherence and Outcomes with Urate-Lowering Therapy: A Site-Randomized Trial.
    Mikuls TR; Cheetham TC; Levy GD; Rashid N; Kerimian A; Low KJ; Coburn BW; Redden DT; Saag KG; Foster PJ; Chen L; Curtis JR
    Am J Med; 2019 Mar; 132(3):354-361. PubMed ID: 30503879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allopurinol adherence, persistence and patterns of use in individuals with diabetes and gout: A retrospective, population-based cohort analysis.
    Weisman A; Tomlinson GA; Lipscombe LL; Perkins BA; Hawker GA
    Semin Arthritis Rheum; 2021 Dec; 51(6):1162-1169. PubMed ID: 34555659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of persistence rates between allopurinol and febuxostat as first-line urate-lowering therapy in patients with gout: an 8-year retrospective cohort study.
    Kim A; Kim Y; Kim GT; Ahn E; So MW; Lee SG
    Clin Rheumatol; 2020 Dec; 39(12):3769-3776. PubMed ID: 32458236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suboptimal physician adherence to quality indicators for the management of gout and asymptomatic hyperuricaemia: results from the UK General Practice Research Database (GPRD).
    Mikuls TR; Farrar JT; Bilker WB; Fernandes S; Saag KG
    Rheumatology (Oxford); 2005 Aug; 44(8):1038-42. PubMed ID: 15870145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.